O-(substituted benzyl) phosphoramidate compounds and therapeutic use

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 9095599
SERIAL NO

13978272

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This application discloses novel phosphoramidate and phosphonoamidate prodrugs of nucleosides, nucleotides, C-nucleosides, C-nucleotides, phosphonates, and other alcohol-containing drugs; use of these prodrugs for treatment of infectious diseases and cancers, in particular, liver infections and cancers; and methods of preparing these novel phosphoramidate and phosphonoamidate prodrugs.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
HENAN GENUINE BIOTECH CO LTDCOURTYARD NO 10 MIDDLE SECTION OF FUXING ROAD XINCHENG DISTRICT PINGDINGSHAN 467036

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Chang, Junbiao Zhengzhou, CN 16 135
Wang, Zheng Suzhou, CN 534 5554
Zhou, Suping Philadelphia, US 2 63

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Feb 4, 2027
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00